A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Wake Forest University Health Sciences
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
Merck Sharp & Dohme LLC
European Organisation for Research and Treatment of Cancer - EORTC
Novartis
Children's Oncology Group
Celtic Pharma Development Services
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Children's Oncology Group
European Organisation for Research and Treatment of Cancer - EORTC
Celtic Pharma Development Services
European Organisation for Research and Treatment of Cancer - EORTC
Heidelberg University
Case Comprehensive Cancer Center
Neuro-Oncology Working Group of the German Cancer Society
Assistance Publique - Hôpitaux de Paris